Truncated TERT mRNA transfected dendritic cells evoke TERT specific antitumor response in vivo

Hepato-Gastroenterology

Volumn 54, Issue 75, 2007, Pages 681-687

  Qiu, Jian ^a   Li, Guo Wei ^a   Sui, Yan Fang ^b   Sun, Yu Jing ^b   Huang, Ya Yu ^b   Si, Shao Yan ^b   Ge, Wei ^b   Song, Hong Ping ^b  

^a XI'AN JIAOTONG UNIVERSITY   (China)

^b FOURTH MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Antitumor; Dendritic cell; Immune; TERT

Indexed keywords

ENHANCED GREEN FLUORESCENT PROTEIN; GAMMA INTERFERON; LACTATE DEHYDROGENASE; MESSENGER RNA; TELOMERASE REVERSE TRANSCRIPTASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; CANCER IMMUNIZATION; CELL ISOLATION; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DRUG INHIBITION; ELECTROPORATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE SEQUENCE; GENETIC TRANSCRIPTION; GENETIC TRANSFECTION; IMMUNE RESPONSE; IMMUNOPROPHYLAXIS; IN VITRO STUDY; IN VIVO STUDY; INOCULATION; MELANOMA CELL; MOLECULAR CLONING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; TUMOR GROWTH;

ANIMALS; CANCER VACCINES; CLONING, MOLECULAR; DENDRITIC CELLS; ELECTROPORATION; FEMALE; GREEN FLUORESCENT PROTEINS; MICE; MICE, INBRED STRAINS; NEOPLASM TRANSPLANTATION; NEOPLASMS; RNA, MESSENGER; SEQUENCE DELETION; T-LYMPHOCYTES, CYTOTOXIC; TELOMERASE; TRANSFECTION; VACCINATION;

EID: 34250375692     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Greider CW, Blackburn EH: Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 1985; 43(2Pt 1):405-413.
2. Morin GB: The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats. Cell 1989; 59(3):521-9.
3. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL, Coviello GM, Wright WE, Weinrich SL, Shay JW: Specific association of human telomerase activity with immortal cells and cancer. Science 1994; 266(5193):2011-2015.
4. Shay JW, Bacchetti S: A survey of telomerase activity in human cancer. Eur J Cancer. 1997; 33(5):787-791.
5. Hahn WC, Counter CM, Lundberg AS, Beijersbergen RL, Brooks MW, Weinberg RA: Creation of human tumour cells with defined genetic elements. Nature 1999; 400(67431:464-468.
6. Herbert B, Pitts AE, Baker SI, Hamilton SE, Wright WE, Shay JW, Corey DR: Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death. Proc Natl Acad Sci USA 1999; 96(25):14276-14281.
7. Nakayama J, Tahara H, Tahara E, Saito M, Ito K, Nakamura H, Nakanishi T, Tahara E, Ide T, Ishikawa F: Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas. Nat Genet 1998; 18(1):65-68.
8. Counter CM, Meyerson M, Eaton EN, Ellisen LW, Caddle SD, Haber DA, Weinberg RA: Telomerase activity is restored in human cells by ectopic expression of hTERT (hEST2), the catalytic subunit of telomerase. Oncogene 1998; 16(9):1217-1222.
9. Ramakrishnan S, Eppenberger U, Mueller H, Shinkai Y, Narayanan R: Expression profile of the putative catalytic subunit of the telomerase gene. Cancer Res 1998; 58(41:622-625.
10. Vonderheide RH, Hahn WC, Schultze JL, Nadler LM: The telomerase catalytic subunit is a widely expressed tumor-associated antigen recognized by cytotoxic T lymphocytes. Immunity 1999; 10(6):673-679.
11. Nair SK, Heiser A, Boczkowski D, Majumdar A, Naoe M, Lebkowski JS, Vieweg J, Gilboa E: Induction of cytotoxic T cell responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells. Nat Med 2000; 6(9):1011-1017.
12. Minev B, Hipp J, Firat H, Schmidt JD, Langlade-Demoyen P, Zanetti M: Cytotoxic T cell immunity against telomerase reverse transcriptase in humans. Proc Natl Acad Sci USA 2000; 97(91:4796-801.
13. Dong HL, Li ZS, Ye J, Qu P, Huang YY, Wu W, Lu SY, Chen GS, Sui YF: Identification of HLA-A2-restricted CTL epitope encoded by the MAGE-n gene of human hepatocellular carcinoma. Cancer Biol Ther 2004; 3(9):891-898.
14. Lutz MB, Kukutsch N, Ogilvie AL, Rossner S, Koch F, Romani N, Schuler G: An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods 1999; 223(1):77-92.
15. Van Meirvenne S, Straetman L, Heirman C, Dullaers M, De Greef C, Van Tendeloo V, Thielemans K: Efficient genetic modification of murine dendritic cells by electroporation with mRNA. Cancer Gene Ther 2002; 9(9):787-797.
16. Miyahira Y, Murata K, Rodriguez D, Rodriguez JR, Esteban M, Rodrigues MM, Zavala F: Quantification of antigen specific CD8+ T cells using an ELISPOT assay. J Immunol Methods 1995; 181(1):45-54.
17. Rosenberg SA: A new era for cancer immunotherapy based on the genes that encode cancer antigens. Immunity 1999; 10(3):281-287.
18. Boczkowski D, Nair SK, Snyder D, Gilboa E: Dendritic cells pulsed with RNA are potent antigen-presenting cells in vitro and in vivo. J Exp Med 1996; 184(2):465-472.
19. Kalady MF, Onaitis MW, Padilla KM, Emani S, Tyler DS, Pruitt SK: Enhanced dendritic cell antigen presentation in RNA-based immunotherapy. J Surg Res 2002; 105(1):17-24.
20. Ponsaerts P, Van Tendeloo VF, Berneman ZN: Cancer immunotherapy using RNA-loaded dendritic cells. Clin Exp Immunol 2003; 134(3):378-384.
21. Kim KW, Kim SH, Jang JH, Lee EY, Park SW, Um JH, Lee YJ, Lee CH, Yoon S, Seo SY, Jeong MH, Lee ST, Chung BS, Kang CD: Dendritic cells loaded with exogenous antigen by electroporation can enhance MHC class I-mediated antitumor immunity. Cancer Immunol Immunother 2004; 53(4):315-322.
22. Hodes RJ, Hathcock KS, Weng NP: Telomeres in T and B cells. Nat Rev Immunol 2002; 2(9):699-706.
23. Hiyama K, Hirai Y, Kyoizumi S, Akiyama M, Hiyama E, Piatyszek MA, Shay JW, Ishioka S, Yamakido M: Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J Immunol 1995; 155(8):3711-3715.
24. Greenberg RA, Allsopp RC, Chin L, Morin GB, DePinho RA: Expression of mouse telomerase reverse transcriptase during development, differentiation and proliferation. Oncogene 1998; 16(13):1723-1730.